Selexis wins genetic testing contract with University of New Mexico Health Sciences Center

NGS technology platform company Celemics said on the 7th that it had won a contract to supply gene analysis panels and testing services through a tender organized by the University of New Mexico Health Sciences Center (UNMHSC), the largest institution of its kind in New Mexico.

The tender was for a project at UNMHSC to identify genes that make people particularly vulnerable to major respiratory illnesses such as pneumonia, influenza and COVID-19, and to develop new treatments tailored to those genes. Celemics was selected as the final supplier from four targeted sequencing service providers shortlisted. The contract is worth $71,200. The win marks the first proof that Celemics’ products and services can compete in the U.S. tender market. The company said its customized panels stood out against those of local competitors with longer track records.

Founded in 1889, the University of New Mexico is a comprehensive university in Albuquerque. Its Health Sciences Center is the largest integrated healthcare institution in New Mexico. In the latest 2023 U.S. graduate school rankings, its medical school ranked fourth in primary care, while its family medicine program ranked 11th.

Celemics said its ability to develop customized panels tailored to customer requirements was a key factor in winning the contract. After qualifying to supply the Massachusetts state government’s public procurement market, the company said it expects further wins in future tenders.